Imagine a drug so dangerous, it sends one out of every 25 women who take it straight to the emergency room — then imagine your government quietly approving a new version of it as the clock ticked down to a government shutdown. That’s not a dystopian novel. That’s the FDA in 2025.
On September 30, just hours before Congress pulled the plug on government funding, the FDA rushed out an approval for a new generic version of mifepristone — the abortion drug responsible for ending over 60% of U.S. pregnancies terminated today. And this wasn’t some new scientific breakthrough. It was rubber-stamped through an “abbreviated new drug application,” which, in plain English, means: no new safety trials, no updated health data — just a copycat pill with the same deadly side effects.
Let’s not forget: this is the same FDA that recently warned pregnant women against taking Tylenol because it *might* be linked to autism. Yes, Tylenol. But when it comes to a pill designed to end a pregnancy and potentially send the mother to the ER with hemorrhaging, sepsis, or worse? Full speed ahead.
You can’t make this up.
The company behind the new generic, Evita Solutions, submitted its application in October 2021, a few months after Biden’s FDA started using the COVID pandemic as a golden excuse to ditch the requirement for in-person doctor visits before receiving abortion pills. Translation: Big Abortion saw a cash cow, and the Biden bureaucracy opened the barn door.
Today, more than 1.1 million abortions are performed annually in America, and over 63% are done with drugs like mifepristone. This isn’t about “access.” It’s about removing every safeguard so abortion can be delivered like Amazon Prime — no doctor, no questions, no accountability.
And the numbers don’t lie. According to the FDA’s own data, 1 in 25 women who take mifepristone ends up in the emergency room. Independent research says it’s even worse — with 11% suffering severe complications like infections and hemorrhaging. But instead of slowing down, the FDA hit the gas and quietly greenlit a new version of the same poison.
Even Robert F. Kennedy Jr. — hardly a MAGA warrior — called out Biden’s FDA for “twisting” the data to make the drug seem safer than it really is. Democrats love to say they’re the party of science, but when the science screams “danger,” they cover their ears and rubber-stamp the next moneymaking pill.
And let’s talk enforcement. Louisiana Attorney General Liz Murrill is suing over the fact that pro-abortion states are refusing to extradite mail-order abortion pill providers. Some states are even anonymizing prescriptions to make enforcement impossible. In other words, these states are building sanctuary cities — not for immigrants this time — but for abortion drug traffickers.
Stories like Rosalie Markezich’s make it painfully clear what’s at stake. She says her boyfriend forced her to take the abortion pill, and if the FDA had still required an in-person visit with a doctor, he never could’ve gotten his hands on it. She could’ve told a doctor she wanted to keep her baby. But thanks to Biden’s FDA, she didn’t get that chance.
So here we are: a rogue agency, colluding with a profit-hungry abortion industry, approving dangerous drugs in the dead of night, while ignoring the cries of women harmed and the lives lost. This isn’t healthcare. It’s state-sponsored negligence.
President Trump made it clear in his first term: abortion drugs needed strong safeguards, and under his administration, they had them. But the Biden-era FDA threw those protections in the trash. Now it’s up to Trump’s second term to clean up the mess.
The question isn’t whether the FDA should reverse this reckless decision — it’s whether anyone in Washington still has the spine to stand up to Big Pharma and Big Abortion. Because if we can’t protect women from dangerous drugs and unborn children from being erased by mail, what exactly are we protecting?
And how many more midnight approvals are waiting in the FDA’s inbox?